Mocumbi Ana Olga, Ferreira Maria Beatriz, Sidi Daniel, Yacoub Magdi H
Imperial College London, London.
N Engl J Med. 2008 Jul 3;359(1):43-9. doi: 10.1056/NEJMoa0708629.
Endomyocardial fibrosis is the most common restrictive cardiomyopathy worldwide. It has no specific treatment and carries a poor prognosis, since most patients present with advanced heart failure. On the basis of clinical series, regional variations in distribution have been reported within several countries in Africa, Asia, and South America, but large-scale data are lacking on the epidemiologic features and early stages of the disease.
We used transthoracic echocardiography to determine the prevalence of endomyocardial fibrosis in a rural area of Mozambique. We screened a random sample of 1063 subjects of all age groups selected by clustering. Major and minor diagnostic criteria were defined, and a severity score was developed and applied. Cases were classified according to the distribution and severity of the lesions in the heart.
The estimated overall prevalence of endomyocardial fibrosis was 19.8%, or 211 of 1063 subjects (95% confidence interval [CI], 17.4 to 22.2). The prevalence was highest among persons 10 to 19 years of age (28.1%, or 73 of 260 subjects [95% CI, 22.6 to 33.6]) and was higher among male than among female subjects (23.0% vs. 17.5%, P=0.03). The most common form was biventricular endomyocardial fibrosis (a prevalence of 55.5%, or 117 of 211 subjects [95% CI, 48.8 to 62.2]), followed by right-sided endomyocardial fibrosis (a prevalence of 28.0%, or 59 of 211 subjects [95% CI, 21.9 to 34.1]). Most affected subjects had mild-to-moderate structural and functional echocardiographic abnormalities. Only 48 persons with endomyocardial fibrosis (22.7%) were symptomatic. The frequency of familial occurrence was high.
Endomyocardial fibrosis is common in a rural area of Mozambique. By using echocardiography, we were able to detect early, asymptomatic stages of the disease. These findings may aid in the study of the pathogenesis of the disease and in the development of new management strategies.
心内膜心肌纤维化是全球最常见的限制性心肌病。由于大多数患者就诊时已出现晚期心力衰竭,该病尚无特异性治疗方法,预后较差。基于临床系列研究,非洲、亚洲和南美洲的几个国家均报告了该病分布的地区差异,但缺乏关于该病流行病学特征和早期阶段的大规模数据。
我们采用经胸超声心动图来确定莫桑比克一个农村地区心内膜心肌纤维化的患病率。我们通过整群抽样对1063名各年龄组的受试者进行随机抽样筛查。定义了主要和次要诊断标准,并制定和应用了严重程度评分。根据心脏病变的分布和严重程度对病例进行分类。
心内膜心肌纤维化的总体估计患病率为19.8%,即1063名受试者中有211例(95%置信区间[CI],17.4%至22.2%)。患病率在10至19岁人群中最高(28.1%,即260名受试者中有73例[95%CI,22.6%至33.6%]),男性高于女性(23.0%对17.5%,P = 0.03)。最常见的形式是双心室心内膜心肌纤维化(患病率为55.5%,即211名受试者中有117例[95%CI,48.8%至62.2%]),其次是右心内膜心肌纤维化(患病率为28.0%,即211名受试者中有59例[95%CI,21.9%至34.1%])。大多数受影响的受试者有轻度至中度的超声心动图结构和功能异常。只有48例心内膜心肌纤维化患者(22.7%)有症状。家族发病频率较高。
心内膜心肌纤维化在莫桑比克的一个农村地区很常见。通过使用超声心动图,我们能够检测到该病的早期无症状阶段。这些发现可能有助于研究该病的发病机制和制定新的管理策略。